NCT05288062View on ClinicalTrials.gov

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

February 25, 2024

Study Completion Date

July 25, 2024

Conditions
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell MyelomaSmoldering Plasma Cell Myeloma
Interventions
PROCEDURE

Bone Marrow Biopsy

Undergo bone marrow aspirate/biopsy

DRUG

Dexamethasone

Given orally

DRUG

Lenalidomide

Given orally

DRUG

Pomalidomide

Given orally

Trial Locations (4)

55905

Mayo Clinic in Rochester, Rochester

85054

Mayo Clinic Hospital in Arizona, Phoenix

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER